230 related articles for article (PubMed ID: 9876226)
1. Granulocyte/macrophage-colony stimulating factor in allergen-induced rhinitis: cellular localization, relation to tissue eosinophilia and influence of topical corticosteroid.
Nouri-Aria KT; Masuyama K; Jacobson MR; Rak S; Lowhagen O; Schotman E; Hamid Q; Durham S
Int Arch Allergy Immunol; 1998 Dec; 117(4):248-54. PubMed ID: 9876226
[TBL] [Abstract][Full Text] [Related]
2. Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: effect of topical corticosteroids.
Masuyama K; Till SJ; Jacobson MR; Kamil A; Cameron L; Juliusson S; Lowhagen O; Kay AB; Hamid QA; Durham SR
J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):610-7. PubMed ID: 9802369
[TBL] [Abstract][Full Text] [Related]
3. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
Masuyama K; Jacobson MR; Rak S; Meng Q; Sudderick RM; Kay AB; Lowhagen O; Hamid Q; Durham SR
Immunology; 1994 Jun; 82(2):192-9. PubMed ID: 7927488
[TBL] [Abstract][Full Text] [Related]
4. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy.
Ghaffar O; Laberge S; Jacobson MR; Lowhagen O; Rak S; Durham SR; Hamid Q
Am J Respir Cell Mol Biol; 1997 Jul; 17(1):17-24. PubMed ID: 9224205
[TBL] [Abstract][Full Text] [Related]
5. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge.
Rak S; Jacobson MR; Sudderick RM; Masuyama K; Juliusson S; Kay AB; Hamid Q; Löwhagen O; Durham SR
Clin Exp Allergy; 1994 Oct; 24(10):930-9. PubMed ID: 7842362
[TBL] [Abstract][Full Text] [Related]
6. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
[TBL] [Abstract][Full Text] [Related]
7. Expression of IL-4, Cepsilon RNA, and Iepsilon RNA in the nasal mucosa of patients with seasonal rhinitis: effect of topical corticosteroids.
Cameron LA; Durham SR; Jacobson MR; Masuyama K; Juliusson S; Gould HJ; Lowhagen O; Minshall EM; Hamid QA
J Allergy Clin Immunol; 1998 Mar; 101(3):330-6. PubMed ID: 9525448
[TBL] [Abstract][Full Text] [Related]
8. In vivo expression of signal transducer and activator of transcription factor 6 (STAT6) in nasal mucosa from atopic allergic rhinitis: effect of topical corticosteroids.
Ghaffar O; Christodoulopoulos P; Lamkhioued B; Wright E; Ihaku D; Nakamura Y; Frenkiel S; Hamid Q
Clin Exp Allergy; 2000 Jan; 30(1):86-93. PubMed ID: 10606935
[TBL] [Abstract][Full Text] [Related]
9. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia.
Durham SR; Ying S; Varney VA; Jacobson MR; Sudderick RM; Mackay IS; Kay AB; Hamid QA
J Immunol; 1992 Apr; 148(8):2390-4. PubMed ID: 1560199
[TBL] [Abstract][Full Text] [Related]
10. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.
Weido AJ; Reece LM; Alam R; Cook CK; Sim TC
Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780
[TBL] [Abstract][Full Text] [Related]
11. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge.
Erin EM; Zacharasiewicz AS; Nicholson GC; Tan AJ; Higgins LA; Williams TJ; Murdoch RD; Durham SR; Barnes PJ; Hansel TT
Clin Exp Allergy; 2005 Dec; 35(12):1608-14. PubMed ID: 16393327
[TBL] [Abstract][Full Text] [Related]
12. Preventive treatment of intranasal fluticasone propionate reduces cytokine mRNA expressing cells before and during a single nasal allergen provocation.
Kleinjan A; Holm AF; Dijkstra MD; Boks SS; Severijnen L; Mulder PG; Fokkens WJ
Clin Exp Allergy; 2000 Oct; 30(10):1476-85. PubMed ID: 10998026
[TBL] [Abstract][Full Text] [Related]
13. Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid.
Bradding P; Feather IH; Wilson S; Holgate ST; Howarth PH
Am J Respir Crit Care Med; 1995 Jun; 151(6):1900-6. PubMed ID: 7767538
[TBL] [Abstract][Full Text] [Related]
14. Expression of IL-16 in allergen-induced late-phase nasal responses and relation to topical glucocorticosteroid treatment.
Laberge S; Durham SR; Ghaffar O; Rak S; Center DM; Jacobson M; Hamid Q
J Allergy Clin Immunol; 1997 Oct; 100(4):569-74. PubMed ID: 9338554
[TBL] [Abstract][Full Text] [Related]
15. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics.
Broide DH; Paine MM; Firestein GS
J Clin Invest; 1992 Oct; 90(4):1414-24. PubMed ID: 1401075
[TBL] [Abstract][Full Text] [Related]
16. Chronic hyperplastic sinusitis: association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony-stimulating factor and interleukin-3.
Hamilos DL; Leung DY; Wood R; Meyers A; Stephens JK; Barkans J; Meng Q; Cunningham L; Bean DK; Kay AB
J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 1):39-48. PubMed ID: 8335853
[TBL] [Abstract][Full Text] [Related]
17. Immediate effect of topical budesonide on allergen challenge-induced nasal mucosal fluid levels of granulocyte-macrophage colony-stimulating factor and interleukin-5.
Linden M; Svensson C; Andersson E; Andersson M; Greiff L; Persson CG
Am J Respir Crit Care Med; 2000 Nov; 162(5):1705-8. PubMed ID: 11069800
[TBL] [Abstract][Full Text] [Related]
18. Increase in IL-8, IL-10, IL-13, and RANTES mRNA levels (in situ hybridization) in the nasal mucosa after nasal allergen provocation.
KleinJan A; Dijkstra MD; Boks SS; Severijnen LA; Mulder PG; Fokkens WJ
J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):441-50. PubMed ID: 10069878
[TBL] [Abstract][Full Text] [Related]
19. [Fluticasone propionate reduced the production of GM-CSF, IL-6 and IL-8 generated from cultured nasal epithelial cells].
Ohnishi M; Takizawa R; Ohkubo K; Yokosima K; Okuda M; Yagi T
Arerugi; 1994 Mar; 43(3):441-7. PubMed ID: 8198453
[TBL] [Abstract][Full Text] [Related]
20. Circulating eosinophil/basophil progenitors and nasal mucosal cytokines in seasonal allergic rhinitis.
Linden M; Svensson C; Andersson M; Greiff L; Andersson E; Denburg JA; Persson CG
Allergy; 1999 Mar; 54(3):212-9. PubMed ID: 10321556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
